Status:

UNKNOWN

Evaluation of Cerebral Elastography by Magnetic Resonance: Comparison of Healthy Subjects and Patients With Glial Tumor

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Conditions:

Elasticity Imaging Techniques

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

MRI elastography detects the movement of tissues in the human body and monitors their response to mechanical stress in order to reveal their mechanical properties, like palpation. These depend on the ...

Detailed Description

Initiated in 1996, magnetic resonance elastography detects the movement of tissues in the human body and monitors their response to mechanical stress in order to reveal their mechanical properties. Th...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for healthy subjects will be:
  • Age between 18 and 65 years
  • Ability to hold in an MRI device without moving
  • No known and diagnosed neurological pathologies such as stroke, cerebral surgery, central nervous system tumor, inflammatory disease (such as multiple sclerosis), neurodegenerative disease (such as Alzheimer's, Parkinson's or Creutzfeldt-Jakobes's ), depression
  • Informed consent
  • Inclusion criteria for patients will be:
  • Age between 18 and 65 years
  • Ability to hold in an MRI device without moving
  • Glial tumor greater than 3 mm diagnosed by standard MRI
  • Informed and informed consent
  • Exclusion Criteriafor both patients and healthy subjects will be:
  • Inability to perform an MRI examination : claustrophobia, presence of ferromagnetic metallic foreign bodies, wearing a pace-maker, metallic cardiac prosthetic valve, cochlear implants, vascular clips, insulin pump, pregnancy, breastfeeding..
  • Non-affiliation to a social security scheme (beneficiary or beneficiary)
  • Intercurrent disorder likely to disrupt test results
  • Patient under anticoagulant:

Exclusion

    Key Trial Info

    Start Date :

    July 7 2017

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    July 7 2020

    Estimated Enrollment :

    48 Patients enrolled

    Trial Details

    Trial ID

    NCT03274037

    Start Date

    July 7 2017

    End Date

    July 7 2020

    Last Update

    September 8 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Denis DUCREUX

    Le Kremlin-Bicêtre, France, France